KRAS and breast carcinoma: It is important to note that in addition to their p53 status, MCF-7 and MDA-MB-231 cells differ in the expression of the ER, K-Ras, and other important cancer signaling proteins, and whether these factors affect the biological behavior of FAM53A in breast cancer remains to be determined.